Profile data is unavailable for this security.
About the company
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
- Revenue in ILS (TTM)60.26bn
- Net income in ILS-1.86bn
- Incorporated1944
- Employees35.00k
- LocationTeva- Pharmaceutical Industries Ltd.124 Dvora Hanevi'a StTEL AVIV-YAFO 6944020IsraelISR
- Phone+972 39148213
- Fax+972 39234050
- Websitehttps://www.tevapharm.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Viatris Inc | 57.89bn | -211.40m | 47.52bn | 38.00k | -- | 0.6299 | 4.77 | 0.8209 | -0.0499 | -0.0499 | 12.75 | 16.81 | 0.3179 | 2.33 | 5.29 | 404,242.10 | -0.1161 | 0.0887 | -0.1356 | 0.1061 | 43.26 | 40.29 | -0.3652 | 0.2891 | 1.17 | 2.63 | 0.473 | 560.11 | -5.14 | 6.17 | -97.37 | -30.53 | -16.88 | -- |
| Dr Reddy's Laboratories Ltd | 12.64bn | 2.52bn | 48.11bn | 24.83k | 19.13 | 3.77 | 15.13 | 3.81 | 334.61 | 334.61 | 1,680.33 | 1,696.70 | 0.7874 | 1.46 | 3.67 | -- | 15.68 | 11.37 | 21.05 | 16.02 | 70.69 | 66.52 | 19.91 | 14.63 | 1.92 | 41.27 | 0.0662 | 16.40 | 13.54 | 12.64 | 23.75 | 23.39 | 26.78 | 14.87 |
| Zydus Lifesciences Ltd | 8.82bn | 1.73bn | 48.76bn | 23.03k | 28.33 | 5.45 | 23.52 | 5.53 | 37.91 | 38.14 | 193.16 | 197.11 | 0.7103 | 1.82 | 4.06 | -- | 13.92 | 9.05 | 19.29 | 14.01 | 68.14 | 62.16 | 19.60 | 14.33 | 1.51 | 22,696.00 | 0.0351 | 16.48 | 13.40 | 8.23 | 95.25 | 15.72 | -3.03 | -3.04 |
| Incyte Corp | 14.20bn | 2.81bn | 51.50bn | 2.52k | 18.48 | 2.53 | 16.45 | 3.63 | 3.29 | 3.29 | 16.64 | 24.02 | 0.5827 | 4.52 | 5.50 | 1,492,815.00 | 11.53 | 9.07 | 14.16 | 11.02 | 93.73 | 94.97 | 19.78 | 13.68 | 3.43 | -- | 0.006 | 0.00 | 8.87 | 14.45 | 75.42 | 40.41 | -15.06 | -- |
| Cipla Ltd | 11.63bn | 1.86bn | 53.96bn | 26.62k | 29.02 | 4.48 | 22.97 | 4.64 | 51.02 | 51.02 | 319.08 | 330.77 | 0.829 | 1.70 | 5.84 | -- | 13.37 | 10.09 | 16.16 | 12.40 | 65.78 | 59.69 | 16.12 | 12.66 | 2.71 | 58.30 | 0.0205 | 20.79 | 13.28 | 9.51 | 47.10 | 21.96 | 20.68 | 34.08 |
| Divi's Laboratories Ltd | 3.54bn | 721.98m | 55.06bn | 16.95k | 76.26 | 8.99 | 61.69 | 15.55 | 60.27 | 60.27 | 295.54 | 511.21 | 0.5246 | 1.01 | 3.97 | -- | 10.70 | 16.55 | 11.62 | 18.22 | 60.11 | 57.95 | 20.40 | 26.38 | 5.08 | -- | 0.0002 | 34.33 | 0.9976 | 9.66 | -12.25 | 3.41 | 6.47 | 13.40 |
| Sandoz Group AG | -416.89bn | -416.89bn | 58.31bn | 23.85k | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 7.23 | -- | -90.92 | -- | -- | -- |
| Biomarin Pharmaceutical Inc | 9.31bn | 774.22m | 58.77bn | 3.40k | 77.74 | 3.07 | 50.18 | 6.31 | 1.06 | 1.06 | 12.77 | 26.74 | 0.3715 | 0.4993 | 4.00 | 726,740.40 | 3.09 | 0.7116 | 3.54 | 0.8079 | 79.22 | 76.30 | 8.31 | 2.05 | 1.70 | -- | 0.1766 | 0.00 | 15.42 | 10.16 | 36.51 | -- | -5.74 | -- |
| Royalty Pharma plc | 8.44bn | 3.01bn | 58.96bn | 89.00 | 14.69 | 1.82 | 13.14 | 6.99 | 1.78 | 1.78 | 3.73 | 14.41 | 0.1348 | -- | 73.80 | 25,152,370.00 | 7.15 | 9.57 | 9.60 | 12.42 | -- | -- | 53.01 | 67.80 | -- | -- | 0.3836 | 23.47 | 5.24 | 5.58 | 2,549.50 | -3.80 | 50.99 | -- |
| Zhangzhou Pientzhng Phrmctcl Co Ltd | 5.49bn | 1.56bn | 64.48bn | 2.79k | 41.44 | 8.68 | -- | 11.74 | 4.98 | 4.98 | 17.57 | 23.76 | 0.6354 | 1.74 | 13.24 | 3,800,528.00 | 18.30 | 18.82 | 22.61 | 23.91 | 45.77 | 46.55 | 28.81 | 27.98 | 4.02 | -- | 0.0898 | 36.49 | 15.69 | 16.11 | 13.15 | 19.60 | 13.83 | 31.06 |
| Astellas Pharma Inc | 37.43bn | 397.81m | 67.09bn | 14.75k | 169.03 | 1.78 | 16.44 | 1.79 | 9.40 | 9.40 | 892.49 | 890.07 | 0.5322 | 1.38 | 3.33 | 108,694,000.00 | 0.5657 | 4.59 | 0.8492 | 6.61 | 81.76 | 80.53 | 1.06 | 7.98 | 0.7358 | 22.28 | 0.3866 | 86.61 | 5.60 | 4.19 | -82.73 | -40.17 | 9.62 | 13.00 |
| Teva Pharmaceutical Industries Ltd | 60.26bn | -1.86bn | 67.74bn | 35.00k | -- | 2.47 | 55.01 | 1.12 | -1.66 | -1.66 | 53.60 | 24.20 | 0.3712 | 1.96 | 4.64 | 1,721,798.00 | -1.84 | -3.14 | -2.60 | -4.29 | 50.62 | 48.14 | -4.96 | -9.87 | 0.6053 | 4.36 | 0.7226 | -- | 6.17 | -3.42 | 77.15 | -- | -4.17 | -- |
Data as of Jul 02 2024. Currency figures normalised to Teva- Pharmaceutical Industries Ltd.'s reporting currency: Israeli Shekel ILS
10.30%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Norges Bank Investment Managementas of 31 Dec 2023 | 41.03m | 3.66% |
| The Vanguard Group, Inc.as of 31 May 2024 | 36.39m | 3.25% |
| KSM Mutual Funds Ltd.as of 31 Mar 2024 | 10.80m | 0.96% |
| Meitav Mutual Funds Ltd.as of 30 Apr 2024 | 10.12m | 0.90% |
| Migdal Mutual Funds Ltd.as of 31 Mar 2024 | 4.79m | 0.43% |
| Harel Mutual Funds Ltd.as of 31 Mar 2024 | 4.14m | 0.37% |
| Charles Schwab Investment Management, Inc.as of 06 Jun 2024 | 2.57m | 0.23% |
| Canada Pension Plan Investment Boardas of 31 Mar 2023 | 2.26m | 0.20% |
| Psagot Mutual Funds Ltd.as of 31 Mar 2024 | 2.05m | 0.18% |
| DWS Investments (UK) Ltd.as of 06 Jun 2024 | 1.33m | 0.12% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
